109145 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.
Compositions and methods for inducing resistance to soybean cyst nematode via RNAi
#3602siRNA And Their Use In Methods And Compositions For Inhibiting The Expression Of The ORAI1 Gene
#3603siRNA targeting LDHA
#3604Inhibition Of Lactate Transporters For Use In The Treatment Of Inflammatory Diseases
#3605GNAQ targeted dsRNA compositions and methods for inhibiting expression
#3606Targeting metastasis stem cells through a fatty acid receptor (CD36)
#3607RNA nanoparticles for brain tumor treatment
#3608NOVEL CYCLIC CATIONIC LIPIDS AND METHODS OF USE
#3609CYTOCOMPATIBLE HYDROGELS FOR ENCAPSULATION OF CELLS
#3610Use of PLA2G5-deficient suppressive macrophages in suppression of inflammation
#3611Compositions and Methods for Treating Alzheimer's Disease and Other Tauopathies
#3612Nanoparticle-induced fusogenicity between liposome and endosome membranes for targeted delivery through endosomal escape
#3613MASSIVELY PARALLEL COMBINATORIAL GENETICS FOR CRISPR
#3614Methods and compositions for treating atherosclerosis
#3615Compositions and methods for treating beta-hemoglobinopathies
#3616Conserved HBV and HCV sequences useful for gene silencing
#3617METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS
#3618Medicament for liver regeneration and for treatment of liver failure
#3619METHODS OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER
#3620Screening method of anticancer agent focused on function of HP1 and evaluation system
#3621cgb2 And cgb1 Genes; Diagnosis, Monitoring And Treatment Of Cancer
#3622Mutant genes related to drug resistance and relapse of acute lymphoblastic leukaemia and a use thereof
#3623Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3624AAV vectors for treatment of dominant retinitis pigmentosa
#3625System for the biocontrol of disease-transmitting mosquitoes and their eggs using horizontally transferable symbiotic bacteria to deliver pathogen specific interfering RNA polynucleotides
#3626Compositions and methods to promote bone formation and their uses including for the treatment of cancer
#3627Methods and compositions for increased double stranded RNA production
#3628Amphipathic peptide
#3629MEDICAMENT FOR LIVER REGENERATION AND FOR TREATMENT OF LIVER FAILURE
#3630GAMMA-SECRETASE INHIBITION REDUCE APOC3 LEVELS AND PLASMA TRIGLYCERIDES
#3631Antihelminthic medications for pathogenic nematodes
#3632TARGETING PARP1 FOR TREATMENT OF TSC AND CANCERS
#3633Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
#3634POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME
#3635Bio-production of lentiviral vectors
#3636Treatment and diagnosis of inflammatory disorders
#3637In-vitro induction of adult stem cell expansion and derivation
#3638DNA aptamers specific to CD2000R1 and their therapeutic uses
#3639Defined multi-conjugate oligonucleotides
#3640RNA-directed DNA cleavage by the Cas9-crRNA complex
#3641In vivo gene silencing by chemically modified and stable siRNA
#3642Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction
#3643Composition for regulating cell division comprising FCHO1 modulator, and method for regulating cell division using same
#36445′-cyclo-phosphonate modified nucleotides
#3645Amine cationic lipids and uses thereof
#3646Methods and compositions for the activation of gamma-delta T-cells
#3647RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use
#3648RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)
#3649Methods and compositions to treat drug-induced diseases and conditions
#3650Conjugates enhancing total cellular accumulation
#3651Method of treating cancer by using siRNA nanocomplexes
#3652Nanoparticle to target cancer
#3653COMPOSITIONS AND METHODS FOR INSECTICIDAL CONTROL OF STINKBUGS
#3654ANTI-TUMOR THERAPY
#3655RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#3656Therapeutic for treatment of diseases including the central nervous system
#3657Methods Of Treatment For Alpha-1 Antitrypsin Deficiency
#3658LIPID ENCAPSULATING INTERFERING RNA
#3659Nano/micromotors for active and dynamic intracellular payload delivery
#3660Biodegradable vectors for efficient RNA delivery
#3661Niacinamide (NAM) in ischemic tissue injury
#3662Compositions and methods for the treatment of a beta-catenin-associated disease or disorder
#3663Cancer examination method and examination kit
#3664METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3665Methods and compositions for the activation of gamma-delta T-cells
#3666Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
#36675-halouracil-modified microRNAs and their use in the treatment of cancer
#3668Tumor cell malignant transformation suppressor and anti-tumor agent
#3669SIRNA, PHARMACEUTICAL COMPOSITION AND CONJUGATE WHICH CONTAIN SIRNA, AND USES THEREOF
#3670Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
#3671Polypeptide inhibitors of SMAD3 polypeptide activities
#3672RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#3673Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#3674Method and System for the Diagnosis, Prevention or Treatment of Alzheimer s and Related Disease by Measuring, Inhibiting or Arresting Amyloid Plaque Development
#3675Cancer treatment through RLIP76 partial depletion
#3676Cell Differentiation Marker and its Uses
#3677Nucleic acid-polypeptide compositions and uses thereof
#3678Nucleic acid-polypeptide compositions and uses thereof
#3679NOVEL BT TOXIN RECEPTORS AND METHODS OF USE
#3680Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
#3681TLX and MIR-219 as potential therapeutic targets for neurodevelopmental disorders
#3682Microbubble complexes and methods of use
#3683POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF
#3684Technology for the Preparation of Microparticles
#3685RNAi FOR CONTROL OF PHLOEM SAP-FEEDING INSECTS IN CROP PLANTS
#3686Prevention, diagnosis and treatment of cancer overexpressing GPR160
#3687POLYMERASE Q AS A TARGET IN HR-DEFICIENT CANCERS
#3688Methods and compositions using RNA interference for inhibition of KRAS
#3689FATS AS A TARGET FOR TREATING TUMORS AND USES THEREOF
#3690Nucleic acid conjugate
#3691Targeting pleiotrophin signaling to limit high-grade glioma invasion
#3692Polynucleotide nanoparticles for the modulation of gene expression and uses thereof
#3693PRNA three-way junctions
#3694Gene/carrier complex for preventing or treating inflammatory diseases
#3695Molecular marker for cancer stem cell
#3696Double strand RNA-mediated RNA interference through feeding detrimental to larval (gypsy moth)
#3697Compositions and methods for inhibiting expression of CD274/PD-L1 gene
#3698Post-transcriptionally chemically modified double strand RNAs
#3699CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION
#3700CROSS-REGULATION OF TYPE I INTERFERON SIGNALING PATHWAYS
#3701Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA
#3702Methods for reactivating genes on the inactive X chromosome
#3703Method for promoting differentiation of pluripotent stem cells by reducing undifferentiated state thereof
#3704Biodegradable cationic polymers and uses thereof
#3705Method of producing cells resistant to HIV infection
#3706Liposomes for modulating Wiskott-Aldrich syndrome protein
#3707Decreasing lactate level and increasing polypeptide production by down regulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
#3708TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF
#3709Post-transcriptionally chemically modified double strand RNAs
#3710HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL
#3711Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof
#3712BIOLOGICAL MATERIALS AND USES THEREOF
#3713High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereof
#3714MEANS FOR LUNG SPECIFIC DELIVERY
#3715RNA complexes that inhibit melanin production
#3716RNA interference for control of insect pests
#3717High performance multi-input microRNA sensors and uses thereof
#3718NUCLEIC ACID-CONTAINING LIPID PARTICLES AND RELATED METHODS
#3719Process for mixing nucleic acids with transfection reagents for delivery
#3720RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions
#3721Inhibition of oxidative stress in atrial fibrillation
#3722Targeting glioblastoma stem cells through the TLX-TET3 axis
#3723RNA cleavage-induced transcript stabilizer and uses thereof
#3724NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY
#3725RNA nanoparticle for treatment of gastric cancer
#3726Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activities
#3727EGFL6 specific monoclonal antibodies and methods of their use
#3728Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection
#3729Means and methods for treating HBV
#3730TIFA antagonists and their use for treating diseases
#3731Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases
#3732PARENTAL RNAI SUPPRESSION OF KRUPPEL GENE TO CONTROL HEMIPTERAN PESTS
#3733CCR3 MODULATION IN THE TREATMENT OF AGING-ASSOCIATED IMPAIRMENTS, AND COMPOSITIONS FOR PRACTICING THE SAME
#3734Construct for epigenetic modification and its use in the silencing of genes
#3735Interfering RNA molecules
#3736Methods and compositions for modulating gene expression
#3737RNA ligand-displaying exosomes for specific delivery of therapeutics to cell by RNA nanotechnology
#3738Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
#3739Two-tailed self-delivering siRNA
#3740Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interference in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats
#3741Methods and compositions for inhibiting detoxification response
#3742METHOD OF TREATING CANCER
#3743THERAPEUTIC DRUG FOR MALIGNANT TUMORS
#3744PROTOCOL FOR INCREASING LIFE EXPECTANCY IN A TEST SUBJECT
#3745Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)
#3746Reagents for treatment of hepatitis B virus (HBV) infection and use thereof
#3747MOLECULAR TARGETS FOR THE TREATMENT OF WOUNDS, IN PARTICULAR CHRONIC WOUNDS
#3748COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL
#3749METHOD OF MODULATING SURVIVAL AND STEMNESS OF CANCER STEM CELLS BY MDA-9/SYNTENIN (SDCBP)
#3750Treatment using truncated Trk B and Trk C antagonists
#3751Oligonucleotide compositions with enhanced efficiency
#3752Engineered immunostimulatory bacterial strains and uses thereof
#3753Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing
#3754Methods for modulating Ataxin 2 expression
#3755Compositions and methods directed to treating liver fibrosis
#3756Dual molecular delivery of oligonucleotides and peptide containing conjugates
#3757Methods for treating brain metastases using combinations of anti-P13K and anti-mTOR agents
#3758BTK INHIBITORS FOR TREATING NEUROBLASTOMA
#3759Liposomes comprising a calcium phosphate-containing precipitate
#3760Methods and materials for determining pain sensitivity and predicting and treating related disorders
#3761METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3762COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MUTANT EGFR GENE
#3763Targeting WSB1 and pVHL to treat cancer
#3764PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS
#3765RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#3766RNAi agents for inhibiting expression of alpha-ENaC and methods of use
#3767Treatment of heart disease by inhibtion of the action of muscle A-kinase anchoring protein (mAKAP)
#3768Monocarboxylate transporter 4 (MCT) antisense oligonucleotide (ASO) inhibitors for use as therapeutics in the treatment of cancer
#3769Compounds and methods for trans-membrane delivery of molecules
#3770Inhibition of Diacylglycerol Kinase to Augment Adoptive T cell Transfer
#3771Methods of detecting and reducing cancer cell central nervous system colonization
#3772Method for diagnosing and treating ovarian cancer
#3773METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3774METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3775METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3776FLT3 receptor antagonists for the treatment or the prevention of pain disorders
#3777Anti-ADAM33 oligonucleotides and related methods
#3778Methods of treating cancer by inhibition of DNA repair proteins using antisense based therapies
#3779Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#3780RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
#3781DOUBLE-STRANDED OLIGONUCLEOTIDES
#3782Methods and compositions for the specific inhibition of β-catenin by double-stranded RNA
#3783COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA
#3784In vitro cleavage of DNA using argonaute
#3785Methods and pharmaceutical compositions for the treatment of diseases mediated by the NRP-1/OBR complex signaling pathway
#3786Treatment of fibrosis with interleukin-11 antibody
#3787Peptides and nanoparticles for intracellular delivery of molecules
#3788Carrier nanoparticles and related compositions, methods and systems
#3789Nucleic acid-polypeptide compositions and uses thereof
#3790Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#3791USE OF MCOLN-1 MODULATORS TO REGULATE CELL MIGRATION
#3792RNA interference in dermal and fibrotic indications
#3793Compositions and agents against hepatitis B virus and uses thereof
#3794Compositions and methods for controlling arthropod parasite and pest infestations
#3795Identification and use of new tumor-promoting gene in hematological malignancies
#3796Nucleic acid-polypeptide compositions and uses thereof
#3797Treatment of fibrosis with interleukin-11 receptor alpha antibody
#3798Treatment of fibrosis with interleukin-11 receptor alpha antibody
#3799Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
#3800Targeted sensitization of non-del(5q) malignant cells
#3801Lipids and lipid compositions for the delivery of active agents
#3802GENE-MODIFIED LYMPHOCYTES EXPRESSING CHIMERIC ANTIGEN RECEPTOR IN WHICH PRODUCTION OF INFLAMMATORY CYTOKINES IS INHIBITED
#3803AMPHIPHILIC POLYMER MICELLES AND USES THEREOF
#3804Methods and compositions of insect control
#3805Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation
#3806INHIBITORS OF PLRG1 (PLEIOTROPIC REGULATOR 1) FOR PREVENTING OR TREATING CANCER AND METHODS FOR MAKING AND USING THEM
#3807UNA oligomers having reduced off-target effects in gene silencing
#3808Methods and compositions for managing vascular conditions
#3809Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes
#3810RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
#3811ESOPHAGEAL CANCER MARKER AND USE THEREOF
#3812Treatment of fibrosis with interleukin-11 antibody
#3813Treatment of fibrosis with interleukin-11 receptor alpha antibody
#3814Treatment of fibrosis with IL-11 receptor alpha antibody
#3815Treatment of fibrosis with Interleukin-11 receptor alpha antibody
#3816Treatment of fibrosis with interleukin-11 receptor alpha antibody
#3817Treatment of fibrosis with interleukin-11 antibody
#3818Treatment of fibrosis with interleukin-11 antibody
#3819Treatment of fibrosis with interleukin-11 antibody
#3820Treatment of fibrosis with interleukin-11 antibody
#3821REGULATION OF CYTOKINE PRODUCTION
#3822PHARMACEUTICAL COMPOSITION AND A METHOD FOR PRODUCING THEREOF
#3823Compositions and methods for modulating stem cells and uses thereof
#3824MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
#3825MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer
#3826ANTI-INFLUENZA VIRUS AGENT AND SCREENING METHOD FOR ANTI-INFLUENZA VIRUS AGENT
#3827Treatment of tinnitus through modulation of chloride co-transporter NKCC1 in the auditory system
#3828Methods and compositions for delivery of polynucleotides
#3829Organic compositions to treat beta-ENaC-related diseases
#3830METHODS FOR DETERMINING RESISTANCE TO ANTICANCER THERAPY AND COMPOSITION USED THEREFOR
#3831Peptide, Complex of Peptide and siRNA, and Methods of Use Thereof
#3832INHIBITING GENE EXPRESSION WITH dsRNA
#3833Method of treating autoimmune disease with lymphocyte antigen CD5-like (CD5L) protein
#3834LIPIDS FOR DELIVERY OF THERAPEUTICS
#3835POLYMER-LIPID MATERIALS FOR DELIVERY OF NUCLEIC ACIDS
#3836Nucleic acid-containing lipid nanoparticles
#3837ApoCIII and the Treatment and Diagnosis of Diabetes
#3838TENASCIN-W AND BILIARY TRACT CANCERS
#3839METHODS OF DIAGNOSING AND TREATING BREAST CANCER
#3840Pharmaceutical composition for inhibition of cancer cell metastasis including siRNA for ribosomal protein S3
#3841Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference
#3842Serpina1 iRNA compositions and methods of use thereof
#3843System and method for reversible photo-controlled gene silencing
#3844POLYNUCLEOTIDES FOR MULTIVALENT RNA INTERFERENCE, COMPOSITIONS AND METHODS OF USE THEREOF
#3845Delivery method of target material into extracellular vesicles using extracorporeal shockwave
#3846siRNA and their use in methods and compositions for inhibiting the expression of the NRARP gene
#3847Production of viruses in avian eggs
#3848AMPHOTERIC LIPOSOMES COMPRISING IMINO LIPIDS
#3849Tissue selective transgene expression
#3850STRUCTURE SPECIFIC RECOGNITION PROTEIN 1 (SSRP1) NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS
#3851Treatment of C9FTD/ALS by targeting RNA expanded repeat sequences
#3852Culicinae Mosquito TRA-2 RNA Interference Technique to Genetically Produce Maleness Population
#3853Antitumor drug delivery formulation
#3854CELL PENETRATING MOLECULE
#3855METHOD FOR PREPARING RECOMBINANT PROTEINS THROUGH REDUCTION OF rnpA GENE EXPRESSION
#3856Guayule with increased rubber production and yield
#3857Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3
#3858Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection
#3859Means and methods for reducing tumorigenicity of cancer stem cells
#3860Methods and compositions for modulating AAV infection
#3861siRNA compositions that specifically downregulate expression of a variant of the PNPLA3 gene and methods of use thereof for treating a chronic liver disease or alcoholic liver disease (ALD)
#3862Methods and compositions for reducing immunosupression by tumor cells
#3863RNA interference in skin indications
#3864METHODS OF CONTROLLING CELL FATE AND CONSEQUENCES FOR DISEASE
#3865iRNA agents with biocleavable tethers
#3866Tumor-specific anti-EGFR antibody and application thereof
#3867Composition for preventing or treating keloid or hypertrophic scars
#3868Argonaute protein-double stranded RNA complexes and uses related thereto
#3869Fatty acids and their use in conjugation to biomolecules
#3870Modified natural killer cells and natural killer cell lines having increased cytotoxicity
#3871MODULATION OF AXON DEGENERATION
#3872Modulation of ciliogenesis
#3873BIOCOMPATIBLE WATER-SOLUBLE POLYMERS INCLUDING SULFOXIDE FUNCTIONALITY
#3874Soluble MANF in pancreatic beta-cell disorders
#3875Methods and compositions for integration defective lentiviral vectors
#3876Toxic RNAi active seed sequences for killing cancer cells
#3877Methods relating to circulating tumor cell clusters and the treatment of cancer
#3878Methods and Compositions for Selecting siRNA of Improved Functionality
#3879AGE-RELATED MACULAR DEGENERATION TREATMENT
#3880LANOSTEROL 14-ALPHA DEMETHYLASE (CYP51) NUCLEIC ACID MOLECULES THAT CONTROL PATHOGENS
#3881Stem cell with suppressed SOCS and improved immunosuppressive ability and use thereof
#3882COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER FIBROSIS
#3883INTRATHECAL DELIVERY OF NUCLEIC ACID SEQUENCES ENCODING ABCD1 FOR TREATMENT OF ADRENOMYELONEUROPATHY
#3884Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#3885Agents and methods for treating and preventing seborrheic keratosis
#3886Method for determining presence or absence of suffering from malignant lymphoma or leukemia, and agent for treatment and/or prevention of leukemia
#3887POLYAMINATED POLYGLUTAMIC ACID-CONTAINING COMPOUNDS AND USES THEREOF FOR DELIVERING OLIGONUCLEOTIDES
#3888Methods of treating or preventing pruritis by blocking natriuretic polypeptide b
#3889Compounds and methods for modulating C90RF72
#3890Mantle phenotype detection in palm
#3891Ovary Tumor Markers And Methods Of Use Thereof
#3892Methods and compositions related to T-cell activity
#3893Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3894Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3895Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3896TREATMENT FOR CANCER METASTASIS
#3897Agents and methods to elicit anti-tumor immune response
#3898Application of PCSK9 inhibitors in the preparation of drugs for the treatment of inflammatory immune diseases
#3899Leg1 Protein, Leg1 Gene, and Uses and Drugs thereof
#3900Substituted thiazoles for preventing and/or treating cell or tissue necrosis